Johnson & Johnson hopes to submit emergency use authorization application next month for its vaccine
New Brunswick-based Johnson & Johnson says it hopes to submit an emergency use authorization application next month to the FDA for its vaccine.
According to the company, it should soon have enough data to determine if its Janssen vaccine is safe and effective against COVID-19.
Johnson & Johnson hopes to have its data “toward the end of January.”
The Janssen vaccine is a single dose shot, unlike some other vaccines.